By Staff Reporters
***
***
CVS is overhauling how it prices prescription drugs
In a recent announcement, the company CVS promised that its new model would be more transparent than the current setup, which prices drugs based on complex reimbursement formulas that can make the costs of prescriptions confusing for consumers.
CITE: https://www.r2library.com/Resource/Title/082610254
The new model, called CVS CostVantage, is based on a simple equation: Drugs will cost what CVS paid for them, plus a limited markup and a flat fee to cover the services of fulfilling the prescriptions. That’s similar to a plan proposed by billionaire Mark Cuban, founder of Cost Plus Drugs, to bring accountability to drug pricing in the US.
MORE: https://medicalexecutivepost.com/2022/06/23/mark-cubans-cost-plus-drugs-com/
COMMENTS APPRECIATED
Thank You
***
***
Filed under: "Doctors Only", Accounting, Drugs and Pharma, Ethics, Health Economics | Tagged: Cost plus Drugs, CVs, CVS cost advantage, drug prices, Mark Cuban, PBM, prescription drugs, prescriptions, Rx drugs | Leave a comment »














